Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | AKT1 | P31749 | 3/20 | 0.60 |
| ▸ | CDC25A | P30304 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.60 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TERT | O14746 | 1/20 | 0.45 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4639710 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| SCHEMBL3967255 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| SCHEMBL3240611 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| SCHEMBL11675710 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| SCHEMBL16371727 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| SCHEMBL23112858 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| SCHEMBL11675849 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| SCHEMBL3965401 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| SCHEMBL9584746 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 | |
| Zinc Ion SCHEMBL945566 | 0.95 | CYP3A4 (0.61) | CYP3A4AKT1CDC25ALMNAESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3969490-B1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS | BRIDGESTONE CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12410263-B2 | Modified high-Cis polybutadiene polymer, related methods and rubber compositions | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-12264232-B2 | Modified high-cis polybutadiene polymer, related methods and tire components | BRIDGESTONE CORPORATION (JP) | 2025-04-01 | — | — | US | disclosed |
| US-20250066516-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | BRIDGESTONE CORPORATION (JP) | 2025-02-27 | — | — | US | disclosed |
| CN-113825777-B | Modified high cis polybutadiene polymers, related methods and tire components | 株式会社普利司通 | 2025-01-28 | — | — | CN | disclosed |
| EP-4495146-A2 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | Bridgestone Americas Tire Operations, LLC (US) | 2025-01-22 | — | — | EP | disclosed |
| EP-4457250-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | Bridgestone Corporation (JP) | 2024-11-06 | — | — | EP | disclosed |
| EP-3966259-B1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | BRIDGESTONE AMERICAS TIRE OPERATIONS LLC (US) | 2024-10-30 | — | — | EP | disclosed |
| CN-118574860-A | Hydrogenated polybutadiene polymer and rubber composition containing the same | 株式会社普利司通 | 2024-08-30 | — | — | CN | disclosed |
| EP-1416528-A2 | Method of forming cavity between multilayered wirings | JSR Corporation (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1195397-B1 | Composition of cyclic olefin addition copolymer and cross-linked material | JSR CORP (JP) | 2004-04-14 | — | — | EP | disclosed |
| US-6699813-B2 | COMPOSITION THAT IS COMBINATION OF OR REACTION PRODUCT OF LANTHANIDE COMPOUND, ALKYLATING AGENT, NICKEL-CONTAINING COMPOUND, AND OPTIONALLY HALOGEN-CONTAINING COMPOUND THAT INCLUDES ONE OR MORE LABILE HALOGEN ATOMS | BRIDGESTONE CORPORATION (JP) | 2004-03-02 | — | — | US | disclosed |
| US-20030176276-A1 | Lanthanide-based catalyst composition for the manufacture of polydienes | BRIDGESTONE CORPORATION (JP) | 2003-09-18 | — | — | US | disclosed |
| US-20030119961-A1 | Cyclic olefin addition copolymer and process for producing same, crosslinking composition, crosslinked product and process for producing same, and optically transparent material and application thereof | JSR CORPORATION (JP) | 2003-06-26 | — | — | US | disclosed |
| EP-1293521-A2 | Cyclic olefin addition copolymer and process for producing same, crosslinking composition, crosslinked product and process for producing same, and optically transparent material and application thereof | JSR Corporation (JP) | 2003-03-19 | — | — | EP | disclosed |
| US-20020042461-A1 | Composition of cyclic olefin addition copolymer and cross-linked material | JSR CORPORATION (JP) | 2002-04-11 | — | — | US | disclosed |
| EP-1195397-A1 | Composition of cyclic olefin addition copolymer and cross-linked material | JSR Corporation (JP) | 2002-04-10 | — | — | EP | disclosed |
| US-4111839-A | NICKEL BIS-ORGANO-ORTHOSPHOSPHATE COMBINATION CATALYST | ANDERSON DEVELOPMENT COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4060513-A | BENZOPHENONE U.V. STABILIZERSPOLYOLEFIN | CINCINNATI MILACRON, INC. (US) | 1977-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | MALT1, INO80C, RTCB | CYP3A4 1440/4885AKT1 3085/4885CDC25A 2965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.